476 related articles for article (PubMed ID: 33552068)
21. Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A review.
Fan Y; Ma Z; Zhao L; Wang W; Gao M; Jia X; Ouyang H; He J
Biomed Pharmacother; 2020 Dec; 132():110820. PubMed ID: 33035836
[TBL] [Abstract][Full Text] [Related]
22. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
23. Traditional Chinese medicine (TCM) as a source of new anticancer drugs.
Yao CL; Zhang JQ; Li JY; Wei WL; Wu SF; Guo DA
Nat Prod Rep; 2021 Sep; 38(9):1618-1633. PubMed ID: 33511969
[TBL] [Abstract][Full Text] [Related]
24. [Research initiative of new thought on "main effect" of TCM formulae--new thinking on mechanism of compound action and compatibility mechanism of Chinese herbal compound formulae].
Weng XG; Li YJ; Chen Y; Yang Q; Wang YJ; Li Q; Cai WY; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(18):3782-3786. PubMed ID: 30384546
[TBL] [Abstract][Full Text] [Related]
25. The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine.
Chen P; Zhang J; Wang C; Chai YH; Wu AG; Huang NY; Wang L
Phytomedicine; 2022 Jun; 100():154044. PubMed ID: 35338993
[TBL] [Abstract][Full Text] [Related]
26. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.
Wang E; Bussom S; Chen J; Quinn C; Bedognetti D; Lam W; Guan F; Jiang Z; Mark Y; Zhao Y; Stroncek DF; White J; Marincola FM; Cheng YC
BMC Med Genomics; 2011 May; 4():38. PubMed ID: 21569348
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of Traditional Chinese medicine/natural medicine in HR-positive Breast Cancer: A comprehensive Literature Review.
Yu Q; Xu C; Song J; Jin Y; Gao X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117322. PubMed ID: 37866466
[TBL] [Abstract][Full Text] [Related]
28. Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy.
Yang C; Li D; Ko CN; Wang K; Wang H
Front Immunol; 2023; 14():1133050. PubMed ID: 36969211
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment.
Sun K; Wu L; Wang S; Deng W
Front Oncol; 2022; 12():949332. PubMed ID: 36212483
[TBL] [Abstract][Full Text] [Related]
30. Research progress in the treatment of slow transit constipation by traditional Chinese medicine.
Wang L; Wu F; Hong Y; Shen L; Zhao L; Lin X
J Ethnopharmacol; 2022 May; 290():115075. PubMed ID: 35134487
[TBL] [Abstract][Full Text] [Related]
31. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells.
Wang Y; Xie L; Liu F; Ding D; Wei W; Han F
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117299. PubMed ID: 37816474
[TBL] [Abstract][Full Text] [Related]
32. Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells.
Xu J; Song Z; Guo Q; Li J
Biomed Res Int; 2016; 2016():1490738. PubMed ID: 27042656
[TBL] [Abstract][Full Text] [Related]
33. Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese.
Li X; Yang G; Li X; Zhang Y; Yang J; Chang J; Sun X; Zhou X; Guo Y; Xu Y; Liu J; Bensoussan A
PLoS One; 2013; 8(4):e60338. PubMed ID: 23560092
[TBL] [Abstract][Full Text] [Related]
34. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer.
Yang Z; Zhang Q; Yu L; Zhu J; Cao Y; Gao X
J Ethnopharmacol; 2021 Jan; 264():113249. PubMed ID: 32810619
[TBL] [Abstract][Full Text] [Related]
35. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
[TBL] [Abstract][Full Text] [Related]
36. The traditional chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun.
Yu P; Wei H; Li K; Zhu S; Li J; Chen C; Zhang D; Li Y; Zhu L; Yi X; Liu N; Liu P; Zhao S; Chen X; Peng C
J Exp Clin Cancer Res; 2022 Dec; 41(1):346. PubMed ID: 36522774
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacological effect of combined administration of natures, tastes and components of Chinese herbal compounds].
Lv CY; Lv SW; Li GY; Kuang HX
Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(6):1099-1103. PubMed ID: 29676114
[TBL] [Abstract][Full Text] [Related]
38. Research status of pathogenesis of anxiety or depression after percutaneous coronary intervention and Traditional Chinese Medicine intervention.
Ning B; Ge T; Zhao QQ; Feng LS; Wu YQ; Chen H; Lian K; Zhao MJ
J Ethnopharmacol; 2024 Jun; 327():118017. PubMed ID: 38462028
[TBL] [Abstract][Full Text] [Related]
39. Prescriptions of traditional Chinese medicine are specific to cancer types and adjustable to temperature changes.
Chiu PH; Hsieh HY; Wang SC
PLoS One; 2012; 7(2):e31648. PubMed ID: 22359613
[TBL] [Abstract][Full Text] [Related]
40. Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment.
Ma Z; Fan Y; Wu Y; Kebebe D; Zhang B; Lu P; Pi J; Liu Z
Int J Nanomedicine; 2019; 14():2029-2053. PubMed ID: 30962686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
